Distinct epigenetic and transcriptional profiles of Epstein-Barr virus-positive and negative primary CNS lymphomas
Neuro-Oncology · 15.05.2025 · 27 (4) · 979-992
DOI: 10.1093/neuonc/noae251 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuro-Oncology, online erschienen am 22.11.2024. Verfasst von Ling Hai und 18 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Cooperation Unit (CCU) Neuro-Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), …. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, Herpesvirus 4, Human, Central Nervous System Neoplasms, Epigenesis, Genetic. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Epstein-Barr virus (EBV)+ and EBV- primary CNS lymphomas (PCNSL) carry distinct mutational landscapes, but their transcriptional and epigenetic profiles have not been integrated and compared. This precludes further insights into pathobiology and molecular differences, relevant for classification and targeted therapy.
Methods
Twenty-three EBV- and 15 EBV+ PCNSL, histologically classified as diffuse large B-cell lymphomas, were subjected to RNA-sequencing and EPIC methylation arrays. Unsupervised clustering analyses were performed. Differentially expressed and differentially methylated genes were identified and integrated.
Results
Two distinct transcriptional clusters were found, which separated EBV- and EBV+ PCNSL (P < .0001). The EBV+ transcriptional signature contained genes (GPR15, FCER2/CD23, SLAMF1/CD150) closely regulated by EBV oncogenes in B cells. Pathway enrichment analysis uncovered enhanced B-cell receptor (BCR) and WNT/beta-catenin signaling in EBV- lymphomas, whereas Interleukin-10, NOTCH, and viral life cycle pathways were upregulated in EBV+ PCNSL. Correspondingly, BCR-associated SYK kinase activity was enriched in EBV- tumors while JAK2 was overrepresented in EBV+ PCNSL. Epigenetic profiling revealed reduced global promoter methylation in EBV+ PCNSL. Two methylation clusters were recognized, which separated EBV- and EBV+ PCNSL (P < .0001). Epigenetic profiles were distinct from 2,788 other brain tumor and nonmalignant reference samples. Promoter region hypermethylation of CD79B, a BCR subunit critical for sustained proliferation in EBV- disease, highly correlated (R = −0.7) with its transcriptional downregulation in EBV+ PCNSL.
Conclusions
EBV+ and EBV- PCNSL harbor distinct transcriptional and epigenetic profiles, corroborating them as distinctive biological subtypes. Uncovered differences provide novel insights into their pathobiology, may guide molecular diagnostics and targeted therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Cooperation Unit (CCU) Neuro-Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.
- Department of Neurology, University Hospital Heidelberg, Heidelberg University, Heidelberg, Germany.
- Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
- Department of Neuropathology, Heidelberg University Hospital, and Clinical Cooperation Unit (CCU) Neuropathology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heid…
- Division of Applied Bioinformatics, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
- Department of Neurology, Yale School of Medicine, New Haven, Connecticut, USA.
ORCID-Profile: Dennis Friedel, Felix Hinz, Dirk C Hoffmann, Sofia Doubrovinskaia, Hannah Rohdjess, Tobias Kessler, Alexandros Kourtesakis, Christel Herold-Mende, Octavian Henegariu, Joachim M Baehring, Jorg Dietrich, Benedikt Brors, Wolfgang Wick, Felix Sahm, Leon D Kaulen
Zitieren
APA
Hai, L., Friedel, D., Hinz, F., Hoffmann, D. C., Doubrovinskaia, S., Rohdjess, H., Weidenauer, K., Denisova, E., Scheffler, G. T., Kessler, T., Kourtesakis, A., Herold-Mende, C., Henegariu, O., Baehring, J. M., Dietrich, J., Brors, B., Wick, W., Sahm, F., & Kaulen, L. D. (2025). Distinct epigenetic and transcriptional profiles of Epstein-Barr virus-positive and negative primary CNS lymphomas. Neuro-Oncology, 27(4), 979-992. https://doi.org/10.1093/neuonc/noae251
Vancouver
Hai L, Friedel D, Hinz F, Hoffmann DC, Doubrovinskaia S, Rohdjess H, et al. Distinct epigenetic and transcriptional profiles of Epstein-Barr virus-positive and negative primary CNS lymphomas. Neuro-Oncology. 2025;27(4):979-992. doi:10.1093/neuonc/noae251
BibTeX
@article{Hai2025,
author = {Hai, Ling and Friedel, Dennis and Hinz, Felix and Hoffmann, Dirk C and Doubrovinskaia, Sofia and Rohdjess, Hannah and Weidenauer, Katharina and Denisova, Evgeniya and Scheffler, Georg T and Kessler, Tobias and Kourtesakis, Alexandros and Herold-Mende, Christel and Henegariu, Octavian and Baehring, Joachim M and Dietrich, Jorg and Brors, Benedikt and Wick, Wolfgang and Sahm, Felix and Kaulen, Leon D},
title = {Distinct epigenetic and transcriptional profiles of Epstein-Barr virus-positive and negative primary CNS lymphomas},
journal = {Neuro-Oncology},
year = {2025},
volume = {27},
number = {4},
pages = {979--992},
doi = {10.1093/neuonc/noae251}
}
EUVIMED